![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication March 24, 2006.
Revised July 17, 2006.
Accepted for publication July 20, 2006.
PDE4 inhibitors are currently being evaluated as potential therapies for inflammatory airway diseases. However, this class of compounds has been shown to cause an arteritis/vasculitis of unknown etiology in rats and cynomolgus monkeys. Studies in rodents have demonstrated the anti-inflammatory effects of PDE4 inhibitors on LPS-induced airway inflammation. The aim of this work was to assess the direct effects of PDE4 inhibitors on inflammatory cells and cytokine levels in the lung in relation to therapeutic effects. The effects of the PDE4 inhibitors, roflumilast(3-cyclo-propylmethoxy-4-difluoromethoxy-N-[3,5-di-chloropyrid-4-yl]-benzamide) and piclamilast (3-(cyclopentyloxy)-N-(3,5-dichloro-4-pyridyl)-4-methoxybenzamide)), were assessed in vivo, using Balb/c mice, and in vitro, in un-stimulated human endothelial and epithelial cell lines. In Balb/c mice, LPS challenge caused an increase in neutrophils in BAL and lung tissue and BAL TNF-
levels, which were inhibited by treatment with either roflumilast or piclamilast (30-100 mg/kg, s.c.). However, roflumilast and piclamilast alone (100 mg/kg) caused a significant increase in plasma and lung tissue keratinocyte-derived chemokine (KC) levels, and lung tissue neutrophils. In vitro, both piclamilast and roflumilast caused an increase in IL-8 release from HUVEC but not BEAS-2B cells, suggesting that one source of the increased KC may be endothelial cells. At doses that antagonized an LPS-induced inflammatory response, the PDE4 inhibitors possessed pro-inflammatory activities in the lung that may limit their therapeutic potential. The pro-inflammatory cytokines KC and IL-8 therefore may provide surrogate biomarkers, both in pre-clinical animal models and in the clinic, to assess potential pro-inflammatory effects of this class of compounds.
Key words:
LPS, chemokine, cytokine, inflammation, neutrophil, rodent